Kyle Mikson CFA
Stock Analyst at Canaccord Genuity
(4.43)
# 1,193
Out of 4,651 analysts
453
Total ratings
43%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTRX Quanterix | Reiterated: Hold | $4 | $2.59 | +54.44% | 31 | Aug 11, 2026 | |
| SEER Seer, Inc. | Reiterated: Buy | $4 | $2.08 | +92.31% | 4 | Aug 11, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $50 → $60 | $56.09 | +6.97% | 31 | Aug 10, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $27 → $35 | $24.00 | +45.83% | 29 | Aug 10, 2026 | |
| NTRA Natera | Maintained: Buy | $330 → $375 | $309.93 | +21.00% | 37 | Aug 7, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $3 | $1.15 | +160.87% | 34 | Aug 6, 2026 | |
| CAI Caris Life Sciences | Reiterated: Hold | $22 | $21.80 | +0.92% | 9 | Aug 6, 2026 | |
| XGN Exagen | Maintained: Buy | $8 → $9 | $6.66 | +35.14% | 26 | Aug 5, 2026 | |
| GRAL GRAIL | Maintained: Buy | $80 | $67.87 | +17.87% | 15 | Aug 5, 2026 | |
| WGS GeneDx Holdings | Reiterated: Buy | $75 → $90 | $78.08 | +15.27% | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $190 → $205 | $190.89 | +7.39% | 50 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 → $50 | $41.25 | +21.21% | 12 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $118.57 | +1.21% | 3 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 | $157.21 | +30.40% | 41 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $29.62 | +35.04% | 27 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $52.10 | +53.55% | 11 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $145 | $166.83 | -13.09% | 12 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 200p → 180p | 122p | +47.54% | 10 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $271 | $17.62 | +1,435.36% | 1 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.9677 | +210.01% | 19 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.7398 | +35.17% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $0.001 | n/a | 12 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $15 | $16.34 | n/a | 3 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $5.20 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.5374 | n/a | 1 | Mar 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.341827 | n/a | 1 | Jan 28, 2021 |
Quanterix
Aug 11, 2026
Reiterated: Hold
Price Target: $4
Current: $2.59
Upside: +54.44%
Seer, Inc.
Aug 11, 2026
Reiterated: Buy
Price Target: $4
Current: $2.08
Upside: +92.31%
10x Genomics
Aug 10, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $56.09
Upside: +6.97%
Biodesix
Aug 10, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $24.00
Upside: +45.83%
Natera
Aug 7, 2026
Maintained: Buy
Price Target: $330 → $375
Current: $309.93
Upside: +21.00%
Pacific Biosciences of California
Aug 6, 2026
Reiterated: Buy
Price Target: $3
Current: $1.15
Upside: +160.87%
Caris Life Sciences
Aug 6, 2026
Reiterated: Hold
Price Target: $22
Current: $21.80
Upside: +0.92%
Exagen
Aug 5, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $6.66
Upside: +35.14%
GRAIL
Aug 5, 2026
Maintained: Buy
Price Target: $80
Current: $67.87
Upside: +17.87%
GeneDx Holdings
Aug 4, 2026
Reiterated: Buy
Price Target: $75 → $90
Current: $78.08
Upside: +15.27%
Aug 3, 2026
Maintained: Hold
Price Target: $190 → $205
Current: $190.89
Upside: +7.39%
Aug 3, 2026
Maintained: Hold
Price Target: $60 → $50
Current: $41.25
Upside: +21.21%
Aug 3, 2026
Maintained: Buy
Price Target: $120
Current: $118.57
Upside: +1.21%
Aug 2, 2026
Maintained: Buy
Price Target: $205
Current: $157.21
Upside: +30.40%
Aug 2, 2026
Maintained: Buy
Price Target: $40
Current: $29.62
Upside: +35.04%
Aug 2, 2026
Maintained: Buy
Price Target: $80
Current: $52.10
Upside: +53.55%
Jul 28, 2026
Maintained: Hold
Price Target: $145
Current: $166.83
Upside: -13.09%
Jul 14, 2026
Reiterated: Buy
Price Target: 200p → 180p
Current: 122p
Upside: +47.54%
Jun 18, 2026
Reiterated: Buy
Price Target: $271
Current: $17.62
Upside: +1,435.36%
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $0.9677
Upside: +210.01%
May 8, 2026
Reiterated: Hold
Price Target: $1
Current: $0.7398
Upside: +35.17%
Jul 29, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $0.001
Upside: n/a
Jun 1, 2021
Maintained: Buy
Price Target: $13 → $15
Current: $16.34
Upside: n/a
Mar 29, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $5.20
Upside: n/a
Mar 9, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.5374
Upside: n/a
Jan 28, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $0.341827
Upside: n/a